4.7 Article

Exome sequencing in pooled DNA samples to identify maternal pre-eclampsia risk variants

Journal

SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/srep29085

Keywords

-

Funding

  1. Jane and Aatos Erkko Foundation
  2. Paivikki and Sakari Sohlberg Foundation
  3. Research Funds of the University of Helsinki
  4. Government Special state subsidy for Health Sciences (EVO funding) at Helsinki and Uusimaa Hospital District
  5. Novo Nordisk Foundation
  6. Finnish Foundation for Pediatric Research
  7. Emil Aaltonen Foundation
  8. Sigrid Juselius Foundation
  9. Biocentrum Helsinki
  10. Doctoral Programme in Biomedicine (DPBM)
  11. Doctoral Programme in Clinical Research (KLTO)
  12. Research Foundation of the University of Helsinki
  13. Biomedicum Helsinki Foundation
  14. Swedish Research Council [K-2013-52X-22198-01-3]
  15. Academy of Finland
  16. Novo Nordisk Fonden [NNF12OC1016374, NNF15OC0016362] Funding Source: researchfish

Ask authors/readers for more resources

Pre-eclampsia is a common pregnancy disorder that is a major cause for maternal and perinatal mortality and morbidity. Variants predisposing to pre-eclampsia might be under negative evolutionary selection that is likely to keep their population frequencies low. We exome sequenced samples from a hundred Finnish pre-eclamptic women in pools of ten to screen for low-frequency, large-effect risk variants for pre-eclampsia. After filtering and additional genotyping steps, we selected 28 low-frequency missense, nonsense and splice site variants that were enriched in the pre-eclampsia pools compared to reference data, and genotyped the variants in 1353 pre-eclamptic and 699 non-pre-eclamptic women to test the association of them with pre-eclampsia and quantitative traits relevant for the disease. Genotypes from the SISu project (n = 6118 exome sequenced Finnish samples) were included in the binary trait association analysis as a population reference to increase statistical power. In these analyses, none of the variants tested reached genome-wide significance. In conclusion, the genetic risk for pre-eclampsia is likely complex even in a population isolate like Finland, and larger sample sizes will be necessary to detect risk variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available